Stay updated with breaking news from Nasdaq Prok. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ProKidney Corp. (NASDAQ:PROK – Get Free Report) SVP Darin J. Weber sold 16,438 shares of the stock in a transaction dated Monday, April 22nd. The shares were sold at an average price of $2.51, for a total value of $41,259.38. Following the completion of the transaction, the senior vice president now owns 155,194 shares of […]
ProKidney (NASDAQ:PROK – Get Free Report) and Cabaletta Bio (NASDAQ:CABA – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability. Volatility and Risk ProKidney has a beta of […]
Social Capital Group LLC decreased its holdings in shares of ProKidney Corp. (NASDAQ:PROK – Free Report) by 12.8% during the 3rd quarter, Holdings Channel.com reports. The fund owned 11,573,000 shares of the company’s stock after selling 1,700,000 shares during the period. ProKidney makes up approximately 89.0% of Social Capital Group LLC’s portfolio, making the stock […]
WINSTON-SALEM, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics...
ProKidney Corp. (NASDAQ:PROK – Get Free Report) major shareholder Chamath Palihapitiya sold 92,500 shares of the company’s stock in a transaction dated Friday, October 27th. The shares were sold at an average price of $1.59, for a total value of $147,075.00. Following the completion of the sale, the insider now directly owns 7,427,000 shares of […]